ArticleNutrients2026
Vitamin D Status and Depressive Symptoms in Patients Undergoing Hemodialysis: A Cross-Sectional Study.
Article in Nutrients, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
BACKGROUND/
objectivesDepressive symptoms are highly prevalent among patients undergoing maintenance hemodialysis. This study investigated the association between vitamin D status and depressive symptom burden in adults undergoing maintenance hemodialysis.
methodsThis cross-sectional study included 91 patients treated at a university hospital in southern Brazil. Depressive symptoms were assessed using the Beck Depression Inventory-II (BDI-II), analyzed as a continuous outcome. Serum 25-hydroxyvitamin D [25(OH)D] was measured by chemiluminescence, and deficiency was defined as <20 ng/mL. Linear regression with HC3 robust standard errors was used, adjusting for age, sex, socioeconomic status, antidepressant or anxiolytic use, and vitamin D supplementation.
resultsSerum 25(OH)D was available for 90 participants, of whom 19 (21.1%) were vitamin D deficient. Mean BDI-II scores were higher in deficient than non-deficient participants (18.4 ± 12.0 vs. 12.4 ± 9.0). Vitamin D deficiency was associated with a 6.00-point higher BDI-II score in the crude model (95% CI 0.07-11.94;
conclusionsVitamin D deficiency was associated with greater depressive symptom burden. However, the association was imprecise, attenuated after sleep adjustment, and absent when 25(OH)D was modeled continuously; causality cannot be established.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.